MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$5,838,000
(-5.86%↓ Y/Y)
Net loss
-$5,838,000
(-6.13%↓ Y/Y)
Loss from operations
-$5,230,000
(6.76%↑ Y/Y)
Other (expense)
income, net
-$608,000
(-662.96%↓ Y/Y)
Total operating
expenses
$5,230,000
(-6.76%↓ Y/Y)
Research and development
$3,073,000
(0.62%↑ Y/Y)
General and
administrative
$2,157,000
(-15.58%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Rein Therapeutics, Inc. (RNTX)
Rein Therapeutics, Inc. (RNTX)